Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating a monoclonal antibody therapy for recurrent Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Lymphoma | Phase 2 | Status: COMPLETED